Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$51.81 - $118.56 $7.69 Million - $17.6 Million
-148,480 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $46.4 Million - $58.3 Million
-417,890 Reduced 73.78%
148,480 $16.5 Million
Q4 2020

Feb 16, 2021

BUY
$88.75 - $119.95 $50.3 Million - $67.9 Million
566,370 New
566,370 $67.3 Million
Q2 2020

Aug 14, 2020

SELL
$84.96 - $118.91 $122 Million - $171 Million
-1,438,356 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$74.34 - $121.82 $66.9 Million - $110 Million
899,394 Added 166.88%
1,438,356 $143 Million
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $37.4 Million - $42.4 Million
327,292 Added 154.62%
538,962 $61.9 Million
Q3 2019

Nov 14, 2019

SELL
$117.16 - $138.52 $16.2 Million - $19.2 Million
-138,520 Reduced 39.56%
211,670 $26.7 Million
Q2 2019

Aug 14, 2019

SELL
$81.74 - $120.34 $82.3 Million - $121 Million
-1,007,220 Reduced 74.2%
350,190 $42.1 Million
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $21.4 Million - $26.3 Million
257,270 Added 23.39%
1,357,410 $119 Million
Q4 2018

Feb 14, 2019

BUY
$90.66 - $116.63 $99.7 Million - $128 Million
1,100,140 New
1,100,140 $110 Million
Q4 2018

Feb 14, 2019

SELL
$90.66 - $116.63 $27.1 Million - $34.9 Million
-299,239 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$89.96 - $114.58 $26.9 Million - $34.3 Million
299,239 New
299,239 $34.3 Million
Q2 2018

Aug 14, 2018

SELL
$71.53 - $95.75 $35.6 Million - $47.6 Million
-497,410 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$60.72 - $74.41 $57.8 Million - $70.9 Million
-952,590 Reduced 65.7%
497,410 $36.4 Million
Q4 2017

Feb 14, 2018

SELL
$44.96 - $58.99 $105,341 - $138,213
-2,343 Reduced 0.16%
1,450,000 $84.2 Million
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $58.6 Million - $65.2 Million
1,452,343
1,452,343 $65.2 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.